// App-Quantinova.ai

TCT-107 : Ticagelor is not superior to clopidogrel in patients with acute coronary syndrome A report from SCAAR

Researchers

Presenter

  • Bjorn Redfors

Principal Investigators

  • Sebastian Volz

  • Oscar Angeras

  • Truls Ramunddal

  • Inger Haraldsson

  • Dan Ioanes

  • Jacob Odenstedt

  • Petur Petursson

  • Lotta Robertsson

  • Jason Stewart

  • Magnus Wahlin

  • Per Albertsson

Medical Centers

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • University of Verona, Gothenburg, Sweden

  • Unknown, Goteborg, Sweden

  • Department of Cardiology, Hisings Backa, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Nu sjukvarden, Trollhattan, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Boras Hospital, Boras, Sweden

  • Cardiology, Skovde, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Cardiogenic shock

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved